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Background
Tau related pathology is the most reliable predictor of
cognitive decline in Alzheimer’s disease. However, it
remains unclear by which mechanisms tau contributes
to neurodegeneration and neuronal dysfunction. The
use of viral vectors provides an effective approach to
replicate cardinal features of tauopathies in the mouse
brain. AAV vectors were designed for overexpression of
various forms of human tau, in order to dissect the
mechanisms underlying tau hyperphosphorylation,
aggregation and neurotoxicity in vivo.
Materials and methods
We generated AAV constructs encoding various forms
of the human tau protein, including wild-type (WT) tau,
a mutant form causing frontotemporal dementia (P301S)
and a tau variant previously reported as aggregation-
deficient (I277P/ I308P). To induce transgene expression
mainly in the forebrain, AAV6 vectors were bilaterally
injected in the lateral ventricles (ICV) of mouse neonates.
The injected mice were analyzed at various time points
to compare the kinetic of the pathology induced by these
different forms of tau. Using histological, biochemical
and ultrastructural analysis, we assessed the deposition
of phosphorylated and aggregated forms of tau, as
well as the induced pathology. Resulting changes in
animal behavioral performances were determined using
specific tests.
Results
AAV-injected mice displayed a somatodendritic and
axonal accumulation of human tau protein in various
brain regions. Pathologic forms of tau, both hyperpho-
sphorylated and misfolded, were found to accumulate as
soon as several weeks post-vector injection. A significant
neurodegeneration was also observed in regions where
tau was expressed at highest level. In addition, mice
injected with WT and P301S tau-expressing vectors
displayed a progressive decline in motor performance,
most severe in the P301S mutant. In contrast, the over-
expression of the I277P/I308P tau variant did not induce
any detectable motor phenotype. Strikingly, the I277P/
I308P tau variant was clearly less hyperphosphorylated
than WT tau, and was associated with cytoskeletal
changes in the axonal and dendritic compartments. Inter-
estingly, the animal motor performance of WT and I277P/
I308P tau expressing animals was significantly correlated
with the abundance of specific tau phospho-epitopes.
Conclusion
Overall, ICV delivery of tau-expressing AAV vectors in
mouse neonates can efficiently induce robust neuronal
tau pathology in the adult forebrain. The resulting accu-
mulation of human tau leads to aggregation, hyperpho-
sphorylation and behavioral defects, including for the
WT form of tau implicated in Alzheimer’s disease. By
allowing side-by-side comparison of different tau variants
in vivo, our approach provides novel insights in the
pathological processes mediated by tau and leading to
neuronal dysfunction and death.
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